Patent Assignment
Reel/Frame 030555/0093
Amended and Restated Sponsored Research Agreement
Recorded: 2013-06-04
Pages: 22
Assignor
FIORUCCI, STEFANO
Executed: 2006-07-01
Assignee
INTERCEPT PHARMACEUTICALS, INC.
421 HUDSON STREET, SUITE 212, NEW YORK, NEW YORK, 10014
Covered Property
(1)
Bile Acid Derivatives As FXR Ligands For The Prevention Or Treatment Of FXR-Mediated Diseases Or Conditions
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 4, 2013
From: PELLICCIARI, ROBERTO; PRUZANSKI, MARK
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 030542/0373 →
Change of Name
Jun 4, 2013
From: INTERCEPT PHARMACEUTICALS, INC.
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 030555/0115 →
Sponsored Research Agreement
Jun 4, 2013
From: FIORUCCI, STEFANO
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 030555/0065 →
Corrective Assignment to Correct the Conveyance Type Previously Recorded on Reel 030555 Frame 0115. Assignor(S) Hereby Confirms the Conveyance Type from Change of Name to Change of Address of Assignee.
Jun 14, 2013
From: INTERCEPT PHARMACEUTICALS, INC.
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 030611/0610 →
Notice of Joint Ownership Claim
Mar 23, 2017
From: FIORUCCI, STEFANO, DR.
To: FIORUCCI, STEFANO, DR.
Reel/Frame 042072/0643 →
Security Interest
Aug 18, 2021
From: INTERCEPT PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 057650/0772 →
Change of Address
Aug 22, 2022
From: INTERCEPT PHARMACEUTICALS, INC.
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 061297/0856 →
Release of Security Interest
Jan 4, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 066662/0210 →